{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:28:11Z","timestamp":1794076091790,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013391","name":"Lesbian Health Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010089","name":"JGW Patterson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pnpbp.2019.109675","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T23:52:40Z","timestamp":1560815560000},"page":"109675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Meta-analysis: Adulthood prevalence of Tourette syndrome"],"prefix":"10.1016","volume":"95","author":[{"given":"Jessica L.S.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Szejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2019.109675_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109675_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpsychores.2009.09.002","article-title":"Clinical course of Tourette syndrome","volume":"67","author":"Bloch","year":"2009","journal-title":"J. Psychosom. Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109675_bb0015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109675_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders","volume":"48","author":"Bloch","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109675_bb0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1176\/ajp.143.6.787","article-title":"Prevalence of Gilles de la Tourette's syndrome in North Dakota adults","volume":"143","author":"Burd","year":"1986","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109675_bb0030","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/mds.21599","article-title":"Malignant Tourette syndrome","volume":"22","author":"Cheung","year":"2007","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109675_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004583-200005000-00008","article-title":"Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder","volume":"39","author":"Coffey","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109675_bb0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","article-title":"Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials","volume":"54","author":"Cohen","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109675_bb0045","series-title":"Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations of Common Diseases","first-page":"1","author":"Food and Drug Adminstration","year":"2018"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2019.109675_bb0050","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/104454603322126313","article-title":"Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?","volume":"13","author":"Geller","year":"2003","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109675_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109675_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1212\/WNL.44.4.699","article-title":"Tourette's syndrome in a special education population: a pilot study involving a single school district","volume":"44","author":"Kurlan","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109675_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: the first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109675_bb0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.eurpsy.2014.07.003","article-title":"Influence of gender on Tourette syndrome beyond adolescence","volume":"30","author":"Lichter","year":"2015","journal-title":"Eur. Psychiatr."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109675_bb0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder","volume":"61","author":"March","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109675_bb0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"Practice parameter for the assessment and treatment of children and adolescents with tic disorders","volume":"52","author":"Murphy","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109675_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4530(92)90015-Y","article-title":"Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome","volume":"17","author":"Peterson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109675_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpsychores.2008.03.007","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes","volume":"65","author":"Robertson","year":"2008","journal-title":"J. Psychosom. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109675_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.26089","article-title":"Population prevalence of Tourette syndrome: a systematic review and meta-analysis","volume":"30","author":"Scharf","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109675_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.eurpsy.2009.10.003","article-title":"Tic disorders: administrative prevalence and co-occurrence with attention-deficit\/hyperactivity disorder in a German community sample","volume":"26","author":"Schlander","year":"2011","journal-title":"Eur. Psychiatr."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109675_bb0105","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/mds.26766","article-title":"The prevalence of diagnosed tourette syndrome in Canada: a national population-based study","volume":"31","author":"Yang","year":"2016","journal-title":"Mov. Disord."},{"issue":"30","key":"10.1016\/j.pnpbp.2019.109675_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004354","article-title":"The prevalence of tic disorders for children in China: a systematic review and meta-analysis","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619302192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619302192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:46:29Z","timestamp":1759520789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619302192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"alternative-id":["S0278584619302192"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109675","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis: Adulthood prevalence of Tourette syndrome","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109675"}}